ONCOGENIC HUMAN PAPILLOMAVIRUSES: High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-Escape.
作者信息
Cid Arregui A, Gariglio P, Kanda T, Doorbar J
机构信息
Translational Immunology Department, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
出版信息
Open Virol J. 2012;6:160-2. doi: 10.2174/1874357901206010160. Epub 2012 Dec 28.
Abstract
摘要
相似文献
1
ONCOGENIC HUMAN PAPILLOMAVIRUSES: High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-Escape.致癌性人乳头瘤病毒：高危型人乳头瘤病毒：深入了解病毒转化、潜伏及免疫逃逸机制
Open Virol J. 2012;6:160-2. doi: 10.2174/1874357901206010160. Epub 2012 Dec 28.
2
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use.人乳头瘤病毒在癌症中的作用：致癌机制与临床应用
Signal Transduct Target Ther. 2025 Jan 24;10(1):44. doi: 10.1038/s41392-024-02083-w.
3
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.人乳头瘤病毒引起的细胞转化：比较高危和低危病毒得出的经验教训。
Virology. 2012 Mar 15;424(2):77-98. doi: 10.1016/j.virol.2011.12.018. Epub 2012 Jan 27.
4
The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors.人乳头瘤病毒的致癌潜力：宿主遗传学和环境辅助因素作用的综述
Br J Dermatol. 2007 Aug;157(2):228-41. doi: 10.1111/j.1365-2133.2007.07961.x. Epub 2007 Jun 6.
5
Natural history of human papillomavirus infection of the anogenital tract.肛管生殖道人类乳头瘤病毒感染的自然史
Cancer Metastasis Rev. 1987;6(4):653-64. doi: 10.1007/BF00047472.
6
Biology and pathological associations of the human papillomaviruses: a review.人乳头瘤病毒的生物学及病理学关联：综述
Malays J Pathol. 1998 Jun;20(1):1-10.
7
Nanopore sequencing of non-oncogenic oral Papillomaviruses from people living with HIV.对HIV感染者的非致癌性口腔乳头瘤病毒进行纳米孔测序。
Res Sq. 2025 Mar 7:rs.3.rs-6082806. doi: 10.21203/rs.3.rs-6082806/v1.
8
Human alpha and beta papillomaviruses use different synonymous codon profiles.人类α和β乳头瘤病毒使用不同的同义密码子谱。
Virus Genes. 2010 Jun;40(3):329-40. doi: 10.1007/s11262-010-0451-1. Epub 2010 Feb 16.
9
Papillomaviruses and assays for transforming genes.乳头瘤病毒与转化基因检测
Methods Mol Biol. 1992;8:159-74. doi: 10.1385/0-89603-191-8:159.
10
[Oncogenic potential of papillomaviruses].
Klin Onkol. 2013;26(6):399-403. doi: 10.14735/amko2013399.
引用本文的文献
1
Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses.条件重编程的人正常气道上皮细胞在 ALI：新兴病毒的生理模型。
Virol Sin. 2020 Jun;35(3):280-289. doi: 10.1007/s12250-020-00244-z. Epub 2020 Jun 17.
2
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.条件重编程用于患者来源的癌症模型和下一代活体生物库。
Cells. 2019 Oct 27;8(11):1327. doi: 10.3390/cells8111327.
3
Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.采用雅培实时高风险 HPV 检测与传统巢式 PCR 联合高通量扩增产物测序法检测加蓬女性人群宫颈涂片标本中人乳头瘤病毒。
Virol J. 2017 Dec 21;14(1):241. doi: 10.1186/s12985-017-0906-2.
4
hrHPV E5 oncoprotein: immune evasion and related immunotherapies.人乳头瘤病毒16型E5癌蛋白：免疫逃逸及相关免疫疗法
J Exp Clin Cancer Res. 2017 May 25;36(1):71. doi: 10.1186/s13046-017-0541-1.
本文引用的文献
1
Genotype distribution of human papillomaviruses in Japanese women with abnormal cervical cytology.日本宫颈细胞学异常女性中人乳头瘤病毒的基因型分布
Open Virol J. 2012;6:277-83. doi: 10.2174/1874357901206010277. Epub 2012 Dec 28.
2
Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic Mice.携带CCL19、IL-2和HPV16 E7的病毒样颗粒在HLA-A2转基因小鼠中引发保护性T细胞反应。
Open Virol J. 2012;6:270-6. doi: 10.2174/1874357901206010270. Epub 2012 Dec 28.
3
Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach.治疗性人乳头瘤病毒（HPV）疫苗：一种新方法。
Open Virol J. 2012;6:264-9. doi: 10.2174/1874357901206010264. Epub 2012 Dec 28.
4
Immunotherapy of human papilloma virus induced disease.人乳头瘤病毒诱导疾病的免疫疗法。
Open Virol J. 2012;6:257-63. doi: 10.2174/1874357901206010257. Epub 2012 Dec 28.
5
The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.无形的敌人——人乳头瘤病毒如何逃避宿主免疫系统的识别与清除
Open Virol J. 2012;6:249-56. doi: 10.2174/1874357901206010249. Epub 2012 Dec 28.
6
The immune response to papillomavirus during infection persistence and regression.感染持续和消退期间对乳头瘤病毒的免疫反应。
Open Virol J. 2012;6:241-8. doi: 10.2174/1874357901206010241. Epub 2012 Dec 28.
7
Human papillomavirus infections and cancer stem cells of tumors from the uterine cervix.人乳头瘤病毒感染与子宫颈肿瘤的癌症干细胞
Open Virol J. 2012;6:232-40. doi: 10.2174/1874357901206010232. Epub 2012 Dec 28.
8
A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens.十年间对人乳头瘤病毒阳性细胞系和临床样本进行的全球信使核糖核酸及微小核糖核酸分析
Open Virol J. 2012;6:216-31. doi: 10.2174/1874357901206010216. Epub 2012 Dec 28.
9
RNA interference for the treatment of papillomavirus disease.用于治疗乳头瘤病毒疾病的RNA干扰
Open Virol J. 2012;6:204-15. doi: 10.2174/1874357901206010204. Epub 2012 Dec 28.
10
Evidence and impact of human papillomavirus latency.人乳头瘤病毒潜伏的证据及影响
Open Virol J. 2012;6:198-203. doi: 10.2174/1874357901206010198. Epub 2012 Dec 28.
Zotero 插件